BioSpace News Archive

Curebase, and CoBTeK, have announced a collaboration in the context of a cross-border (France & Italy) project in order to test the effectiveness of remote interventions in allowing elderly people to remain autonomous.

Element Biosciences, Inc. today announced a partnership with Watchmaker Genomics demonstrating the value and performance of Watchmaker’s DNA and RNA Library Prep Kits on Element’s AVITI System.

TC Biopharm (Holdings) PLC (“TC BioPharm” or the “Company”) (NASDAQ: TCBP) (NASDAQ: TCBPW), a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and viral indications, is pleased to announce the appointment of 4 new members to its Board of Directors.

PolarityTE, Inc. announced results from a multi-center randomized controlled trial evaluating treatment of Venous Leg Ulcers with its investigational product SkinTE® plus standard of care vs SOC alone.

Poseida Therapeutics, Inc. today announced that Brent Warner has joined the Company as President, Gene Therapy effective February 21, 2022 .

Sysmex Inostics, a global leader in the liquid biopsy revolution for oncology, will introduce HNSCC-SEQ, a highly sensitive Plasma-Safe-SeqS and Next Generation Sequencing (NGS) assay service for head and neck squamous cell carcinomas (HNSCC), at the annual 2022 Molecular Medicine Tri-Conference being held Monday, February 21st through Wednesday, February 23rd in San Diego, California.

Ardelyx, Inc. today announced that it will hold a conference call on Monday February 28, at 4:30 pm Eastern Time to discuss fourth quarter and year-end 2021 financial results and provide a corporate update.

Boundless Bio today announced that Dr. Klaus Wagner has been appointed as Chief Medical Officer.

Applied DNA Sciences, Inc. announced that it has entered into a securities purchase agreement with an institutional investor, providing for the purchase and sale of 1,496,400 shares of common stock at a price of $2.80 per share, in a registered direct offering, resulting in total gross proceeds of approximately $4.2 million, before deducting the placement agent’s fees and other estimated offering expenses.

VirtaMed and Memic Innovative Surgery Ltd. announced a partnership to develop a new virtual reality simulator program to support surgeon skills training for the Hominis® Surgical System.